If you are taking a biologic therapy, such as infliximab (Remicade®), adalimumab (Humira®), vedolizumab (Entyvio®), or ustekinumab (Stelara®), to treat inflammatory bowel disease …

Find out if there is a generic form of Entyvio (vedolizumab) and learn about biosimilars for this biologic drug. Discover the difference between generics and biosimilars and what's in …

Compare Entyvio head-to-head with other drugs for uses, ratings, cost, side effects and interactions.

Apr 16, 2025 · Vedolizumab is the generic name for Entyvio, a biologic therapy used to treat moderate to severe Crohn’s disease and ulcerative colitis.

Jun 3, 2025 · Learn about Entyvio (vedolizumab) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.

Vedolizumab is a prescription medication used for the treatment of ulcerative colitis and Crohn's disease. Learn about this generic drug, uses, side effects, dosages, drug interactions, and …

Jul 31, 2024 · Find patient medical information for Entyvio (vedolizumab) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

ENTYVIO is a biologic treatment for moderate to severe Crohn's disease (CD) or ulcerative colitis (UC). See Safety and Prescribing Information.

Sep 29, 2025 · Discover detailed patent information and market exclusivity data for ENTYVIO Get insights on key patent expiration dates and emerging competition.

Oct 13, 2025 · Entyvio is used to treat moderately to severely active ulcerative colitis (UC) or Crohn's disease in adults. It may help reduce symptoms, achieve remission, and reduce the …